U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519005) titled 'Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure' on April 01.
Brief Summary: The goal of this clinical trial is to evaluate whether extracorporeal perfusion using a gene-edited pig liver can significantly improve liver function and serve as a bridge-to-transplant therapy in patients with severe hepatic failure. It will also assess the survival and functionality of the xenogeneic liver and monitor the safety of the procedure. The main questions it aims to answer are:
* Can extracorporeal perfusion with a gene-edited pig liver significantly improve liver function indicators (including biochemi...